ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Assay and Drug Development Technologies (ISSN 1540-658X) is a bimonthly international peer-reviewed journal published by Mary Ann Liebert Inc. in the United States, dedicated to advancing the fields of drug discovery and assay development. The journal serves as a specialized platform for researchers, pharmaceutical scientists, and methodologists seeking to disseminate innovations in high-throughput screening, in vitro testing technologies, biomarker development, and novel methodologies for drug discovery. While it is indexed in the Science Citation Index (SCI), its standing within the Chinese Academy of Sciences (CAS) journal ranking typically places it in the third or fourth quartile of the medical or pharmaceutical sciences categories, reflecting a moderate impact factor that may fluctuate annually as reported in the Journal Citation Reports (JCR). Although not fully open access, the journal offers open access options for selected articles, catering to a global audience interested in the practical application of innovative technologies in the pharmaceutical industry. Given its focus on technical and methodological research, authors are advised to carefully evaluate the alignment of their work with the journal’s specific scope, as the variability in its impact factor suggests a competitive landscape where rigorous adherence to methodological standards is essential for successful publication.